These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 27843920)

  • 1. Proposing a Simpler Classification of Telogen Effluvium.
    Rebora A
    Skin Appendage Disord; 2016 Sep; 2(1-2):35-38. PubMed ID: 27843920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teloptosis, a turning point in hair shedding biorhythms.
    Piérard-Franchimont C; Piérard GE
    Dermatology; 2001; 203(2):115-7. PubMed ID: 11586007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exogen Hairs in Women with and without Hair Loss.
    Guarrera M; Rebora A
    Skin Appendage Disord; 2017 Oct; 3(4):193-196. PubMed ID: 29177147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telogen effluvium revisited.
    Rebora A
    G Ital Dermatol Venereol; 2014 Feb; 149(1):47-54. PubMed ID: 24566565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Atrophic telogen effluvium' from cytotoxic drugs and a randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans.
    Bleiker TO; Nicolaou N; Traulsen J; Hutchinson PE
    Br J Dermatol; 2005 Jul; 153(1):103-12. PubMed ID: 16029334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Microscopic Examination of Pulled Out Hair in Telogen Effluvium Patients.
    Park SH; Seol JE; Kim DH; Kim H
    Ann Dermatol; 2020 Apr; 32(2):141-145. PubMed ID: 33911725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with profuse hair shedding may reveal anagen hair dystrophy: a diagnostic clue of alopecia areata incognita.
    Quercetani R; Rebora AE; Fedi MC; Carelli G; Mei S; Chelli A; Poli E
    J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):808-10. PubMed ID: 20946585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telogen effluvium: a comprehensive review.
    Rebora A
    Clin Cosmet Investig Dermatol; 2019; 12():583-590. PubMed ID: 31686886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telogen Effluvium: A Review of the Literature.
    Asghar F; Shamim N; Farooque U; Sheikh H; Aqeel R
    Cureus; 2020 May; 12(5):e8320. PubMed ID: 32607303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic telogen effluvium.
    Whiting DA
    Dermatol Clin; 1996 Oct; 14(4):723-31. PubMed ID: 9238330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postpartum Telogen Effluvium Unmasking Traction Alopecia.
    Samrao A; Mirmirani P
    Skin Appendage Disord; 2022 Jul; 8(4):328-332. PubMed ID: 35983466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of patients with telogen effluvium during the pandemic: May the monocytes be responsible for post COVID-19 telogen effluvium?
    Koç Yıldırım S; Erbağcı E; Demirel Öğüt N
    J Cosmet Dermatol; 2022 May; 21(5):1809-1815. PubMed ID: 35201647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of Mast Cells and Mast Cell Degranulation in Scalp Biopsies of Telogen Effluvium.
    Grace SA; Sutton AM; Abraham N; Armbrecht ES; Vidal CI
    Int J Trichology; 2017; 9(1):25-29. PubMed ID: 28761261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telogen Effluvium after SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms.
    Rossi A; Magri F; Sernicola A; Michelini S; Caro G; Muscianese M; Di Fraia M; Chello C; Fortuna MC; Grieco T
    Skin Appendage Disord; 2021 Jul; 21(5):1-5. PubMed ID: 34373830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hair Shedding Evaluation for Alopecia: A Refined Wash Test.
    Li X; Wang X; Wang C; Zhang J; Zhou C
    Clin Cosmet Investig Dermatol; 2022; 15():117-126. PubMed ID: 35115799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telogen Effluvium: A Review.
    Malkud S
    J Clin Diagn Res; 2015 Sep; 9(9):WE01-3. PubMed ID: 26500992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Telogen Effluvium: Is it a Distinct Condition? A Systematic Review.
    Daunton A; Harries M; Sinclair R; Paus R; Tosti A; Messenger A
    Am J Clin Dermatol; 2023 Jul; 24(4):513-520. PubMed ID: 37052778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trichodynia and telogen effluvium in COVID-19 patients: Results of an international expert opinion survey on diagnosis and management.
    Starace M; Iorizzo M; Sechi A; Alessandrini AM; Carpanese M; Bruni F; Vara G; Apalla Z; Asz-Sigall D; Barruscotti S; Camacho F; Doche I; Estrada BD; Dhurat R; Gavazzoni MF; Grimalt R; Harries M; Ioannidis D; McMichael A; Melo DF; Oliveira R; Ovcharenko Y; Pirmez R; Ramot Y; Rudnicka L; Shapiro J; Silyuk T; Sinclair R; Tosti A; Vano-Galvan S; Piraccini BM
    JAAD Int; 2021 Dec; 5():11-18. PubMed ID: 34368790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telogen effluvium.
    Grover C; Khurana A
    Indian J Dermatol Venereol Leprol; 2013; 79(5):591-603. PubMed ID: 23974577
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.